INRATIO PT/INR TEST STRIPS
Report
- Report Number
- 2027969-2014-00914
- Event Type
- Death
- Date Received
- October 8, 2014
- Date of Event
- September 8, 2014
- Report Date
- September 10, 2014
- Manufacturer
- ALERE SAN DIEGO, INC.
- Product Code
- GJS
- PMA / PMN Number
- K092987
- Removal / Correction Number
- Z-0880, 0881, 0882-2015
- Adverse Event
- Yes
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- NC, US
- Reporter Occupation
- OTHER
- Health Professional
- N
Narratives
INVESTIGATION PENDING.
CALLER REPORTED THAT ON (B)(6) 2014, THE PATIENT'S INRATIO INR WAS 3.6 AND THE LABORATORY INR WAS >10.0. THE TIME BETWEEN TESTING WAS TEN (10) MINUTES. THE PATIENT'S THERAPEUTIC RANGE WAS 2.0 - 3.0. IT IS UNKNOWN IF ANY TREATMENT OR MEDICATION CHANGE WAS PERFORMED AT THAT TIME. ON (B)(6) 2014, THE PATIENT WAS HOSPITALIZED FOR HYPERTENSION. THE LABORATORY INR WAS >15.1. THE CALLER COULD NOT PROVIDE ANY INFORMATION REGARDING HOSPITALIZATION OR TREATMENT. ON (B)(6) 2014, CUSTOMER WAS CONTACTED REGARDING ADDITIONAL INFORMATION ON THE PATIENT'S HOSPITAL STAY AND OUTCOME. CUSTOMER REPORTED THAT THE PATIENT EXPIRED ON (B)(6) 2014 RELATED TO HYPOVOLEMIC SHOCK. THOUGH REQUESTED, THE CUSTOMER WOULD NOT PROVIDE ANY ADDITIONAL INFORMATION REGARDING EVENT DUE TO THEIR INTERPRETATION OF THE HIPAA REGULATION. MULTIPLE ATTEMPTS WERE MADE TO OBTAIN ADDITIONAL INFORMATION WITH NO SUCCESS. ON 10/02/2014, EMAIL RECEIVED FROM CUSTOMER REPORTING THAT THE FACILITIES MEDICAL DIRECTOR REVIEWED THE CHART AND THE "PT/INR READINGS WERE UNRELATED TO THE DEATH OF THE PATIENT." NO ADDITIONAL INFORMATION PROVIDED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 631376 | INRATIO PT/INR TEST STRIPS | PROTHROMBIN TIME TEST | GJS | ALERE SAN DIEGO, INC. | 100139 | 349870 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 89-90 | Male | Hospitalization| D | COUMADIN| INRATIO MONITOR SN (B)(4)| INRATIO MONITOR SN (B)(4)| COUMADIN |